News - Brenus Pharma

Poster presentation AACR annual meeting 2022

[DRUG PRODUCT RNA SEQ]

Presentation during AACR Virtual Special Conference 2021

[POC1&2 - Efficacy Results of murine STC1010]

16 September 2021

“Biotechs to watch: Brenus pharma; a vaccine yes, but against colorectal cancer”

During a series dedicated to the region's innovative biotechs, Brenus Pharma was highlighted for the expertise of its STC platform, the encouraging preclinical results and the kickoff of the first fundraising round (Seed).

“Brenus Pharma develops immunotherapy treatments for cancer”

Paul Bravetti (CEO) was interviewed by Vincent Touraine during the "PME Focus" chronicle in BFM Business, and talked about the STC therapy added value for cancer patients with therapeutic issue in relapsing conditions.

13 January 2021

“Therapeutic vaccines against cancer treatment resistance “

Double page dedicated to the STC Technology, Paul B. (CEO) & Benoit.P (Co-Funder & CSO) in the BPI News paper: Public Investment Bank (FR).

11 January 2020

“10 startups looking for partnerships”

During the collaborative week of Lyon Biopole (Health Competitiveness Cluster Auvergne-Rhones-Alpes Region), Brenus Pharma was in the top 10 of the most competitive startups offering a disruptive innovation for medicine

2